BBNX
Beta Bionics, Inc. Common Stock
NASDAQ: BBNX · HEALTHCARE · MEDICAL DEVICES
$17.85
-16.55% today
Updated 2026-10-28
Market cap
$882.02M
P/E ratio
—
P/S ratio
7.41x
EPS (TTM)
$-1.64
Dividend yield
—
52W range
$9 – $33
Volume
1.2M
Beta Bionics, Inc. Common Stock (BBNX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$17.85
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B |
| EPS | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -61.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.